Krämer A, Keller W
EMBO J. 1985 Dec 16;4(13A):3571-81. doi: 10.1002/j.1460-2075.1985.tb04119.x.
We have used a complementation assay to test for activities required for the splicing of pre-mRNA in vitro. During the hypotonic lysis of HeLa cells, two components are released from the nuclei that specifically stimulate splicing in an extract prepared from washed nuclei. The two activities separate during chromatography on DEAE-Sepharose. One of these activities [splicing factor (SF)2] co-purified through several steps with the lariat debranching enzyme and with a nuclease which degrades the linear portion of lariat RNAs. These enzymes could, however, be separated from SF2 by chromatography on heparin-Sepharose. SF2 fractionates as a single protein with an apparent mol. wt. of 50 000. SF2 is resistant to mild heat treatment and to treatment with micrococcal nuclease, but it is inactivated by N-ethylmaleimide, suggesting that it is a protein which is not associated with an essential RNA component. When SF2 is absent in a complementation assay, the generation of both intermediates and final products of the splicing reaction is completely abolished. Thus, SF2 functions in an early step of the splicing process.
我们使用了一种互补分析方法来检测体外前体mRNA剪接所需的活性。在HeLa细胞的低渗裂解过程中,从细胞核中释放出两种成分,它们能特异性地刺激从洗涤过的细胞核制备的提取物中的剪接反应。这两种活性在DEAE-琼脂糖柱层析过程中分离。其中一种活性成分[剪接因子(SF)2]在经过几步纯化后与套索脱支酶以及一种能降解套索RNA线性部分的核酸酶共同纯化。然而,这些酶可以通过肝素-琼脂糖柱层析与SF2分离。SF2作为一种单一蛋白质进行分级分离,其表观分子量为50000。SF2对温和热处理和微球菌核酸酶处理具有抗性,但会被N-乙基马来酰亚胺灭活,这表明它是一种不与必需RNA成分相关的蛋白质。在互补分析中如果没有SF2,剪接反应的中间体和最终产物的生成都会完全被消除。因此,SF2在剪接过程的早期步骤中发挥作用。